+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

Rare Hemophilia Factors - Global Strategic Business Report - Product Thumbnail Image

Rare Hemophilia Factors - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
From
Hemophilia Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Hemophilia Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 143 Pages
  • Global
From
From
From
From
From
From
From
Hemostasis Products - Global Strategic Business Report - Product Thumbnail Image

Hemostasis Products - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
Loading Indicator